Pearl Therapeutics Gains $65M
Redwood City-based Pearl Therapeutics said today that it has raised $65M in a Series D funding round. The round came from its existing investors, which include 5AM Ventures, Clarus Ventures, New Leaf Venture Partners, and Vatera Healthcare Partners. The firm said the funding will go towards Phase 3 trials of its lead product, which is being aimed at treating respiratory disorders.
posted on Tuesday, November 13, 2012 (Link to more information)
Related companies:
Pearl App, LLC
Related stories:
> Pearl Therapeutics Acquired For $1.15 Billion
> Pearl Therapeutics Raises $15.5M
> Pearl.com Gets $25.7M More
> Pearl Therapeutics Gets $69M
> Protagonist Therapeutics Gains $40M
silicontap.com Home